Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Third Wave of the EVAL-PLH (POLYhandicap) Cohort: New Eyes

NCT06811441 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2025-10-13
Last updated
2026-10-13

Condition(s) studied

Polyhandicap

Study summary

The general objective of the EVAL-PolyNE project is to improve the representativeness of the EVAL-PLH cohort by broadening participation in the John Bost Foundation, due to its geographical particularity and its private valence.

Eligibility

Sex
ALL
Min age
3 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Patient with PIMD/Polyhandicap * Patient for whom the legal representative has received the information note of the EVAL-PLH cohort and has not expressed opposition to the collection of patient data; * Patient aged at least 3 years; * Patient affiliated to a health insurance scheme; * Patient treated within the department of the participating center; * Patient for whom the legal representative understands the French language; * Patient with a PIMD/Polyhandicap Family caregivers of patient * Subject identified by the care structure as the reference family caregiver; * Subject aged at least 18 years; * Subject who understands the French language and is able to complete self-questionnaires; * Subject who has received the information notice and has not expressed opposition to participating in this project Institutinal caregivers of patient * Subject identified by the care structure as the reference institutional caregiver of at least one patient included in this project; * Subject aged at least 18 years; * Subject who understands the French language and is able to complete self-questionnaires; * Subject who has received the information notice and has not expressed opposition to participating in this project. Exclusion Criteria: * Patient with PIMD/Polyhandicap * Patient not meeting all inclusion criteria; * Patient in exclusion period of another research protocol at the time of inclusion. Family and Institutional caregivers of patient • Subject not meeting all inclusion criteria

Primary outcome measure(s)

  • Health status of patients with PIMD/Polyhandicap — 2 hours to complete the questionnaire
    Evaluate the health status of patients with PIMD/Polyhandicap using a standardized questionnaire completed by a physician.

Trial sites (6)

FacilityCityRegionStatus
Hôpital Marin de Hendaye Hendaye France Recruiting
Hôpital San Salvadour Hyères France Recruiting
Fondation John Bost La Force France Recruiting
Assistance Publique Des Hopitaux de Marseille Marseille France Not Yet Recruiting
CESAP Paris France Recruiting
Hôpital La Roche Guyon Paris France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06811441 on ClinicalTrials.gov ↗ ← All trials in France